This trial is testing whether Botulinum toxin can help people with Raynaud's Phenomenon who haven't responded to other treatments.
2 Primary · 5 Secondary · Reporting Duration: Performed at 4 weeks, 12 weeks, 16 weeks, 20 weeks, and 24 weeks. Week 16 and week 20 measurements will be performed via telephone interview.
Active Control
36 Total Participants · 3 Treatment Groups
Primary Treatment: 10 units of BT per digit · No Placebo Group · Phase 4
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:New York | 100.0% |
18 - 65 | 100.0% |
Did not meet criteria | 100.0% |